Mural nominated two new development candidates, MURA-8518 a novel binding protein-resistant IL-18 with half-life extension, and MURA-7012, targeted split sub-units of IL-12; Mural anticipates an IND ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback